Related Experiment Video
Updated: May 7, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Technology to optimize pediatric diabetes management and outcomes
Jessica T Markowitz1, Kara R Harrington, Lori M B Laffel
1Joslin Diabetes Center, Pediatric, Adolescent, & Young Adult Section, Boston, MA, 02215, USA, jessica.markowitz@joslin.harvard.edu.
Current Diabetes Reports
|September 19, 2013
Summary
New diabetes technologies offer benefits but require careful consideration of usability and psychosocial factors, especially for pediatric patients. This review examines emerging tools for diabetes management in young people.
Area of Science:
- Endocrinology
- Pediatric Endocrinology
- Digital Health
Background:
- Diabetes management technology is rapidly evolving.
- New technologies present benefits, challenges, and considerations for quality of life, usability, and adoption barriers.
- The interplay between developmental stages and technology adoption is crucial, particularly in pediatric populations.
Purpose of the Study:
- To review newer diabetes management technologies.
- To explore the use of these technologies in the pediatric population (including young adults).
- To focus on the psychosocial factors influencing technology adoption and effectiveness in young individuals with diabetes.
Main Methods:
- Literature review of emerging diabetes technologies.
- Analysis of technologies relevant to pediatric diabetes care.
- Examination of psychosocial aspects associated with technology use in youth.
Main Results:
- Trend technology in blood glucose monitoring.
- Continuous glucose monitoring (CGM) and sensor-augmented insulin pumps with low glucose suspend (LGS) functions.
- Internet applications, mobile applications (apps), text messaging, and online gaming for diabetes management.
Conclusions:
- Emerging technologies in diabetes management require careful evaluation for medical benefits, quality of life impact, and usability.
- Psychosocial factors and developmental stages significantly influence the successful integration of technology in pediatric diabetes care.
- A comprehensive approach considering both technological capabilities and user-specific needs is essential for optimizing diabetes management in young people.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...